Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MED
Upturn stock ratingUpturn stock rating

MEDIFAST INC (MED)

Upturn stock ratingUpturn stock rating
$13.57
Last Close (24-hour delay)
Profit since last BUY-2.65%
upturn advisory
Consider higher Upturn Star rating
BUY since 21 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: MED (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Year Target Price $15

Year Target Price $15

Analyst’s Price TargetsFor last 52 week
$15Target price
Low$11.57
Current$13.57
high$22.66

Analysis of Past Performance

Type Stock
Historic Profit -33.75%
Avg. Invested days 15
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 149.15M USD
Price to earnings Ratio -
1Y Target Price 15
Price to earnings Ratio -
1Y Target Price 15
Volume (30-day avg) -
Beta 0.89
52 Weeks Range 11.57 - 22.66
Updated Date 06/29/2025
52 Weeks Range 11.57 - 22.66
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.64

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -1.29%
Operating Margin (TTM) -1.09%

Management Effectiveness

Return on Assets (TTM) 1.33%
Return on Equity (TTM) -3.32%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -834846
Price to Sales(TTM) 0.27
Enterprise Value -834846
Price to Sales(TTM) 0.27
Enterprise Value to Revenue 0.08
Enterprise Value to EBITDA 1.34
Shares Outstanding 10991000
Shares Floating 9141623
Shares Outstanding 10991000
Shares Floating 9141623
Percent Insiders 3.2
Percent Institutions 76.76

Analyst Ratings

Rating 3
Target Price 15
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

MEDIFAST INC

stock logo

Company Overview

overview logo History and Background

MEDIFAST INC. was founded in 1980. Initially a medical formula provider, it evolved into a weight management and healthy lifestyle company, focusing on meal replacements and coaching.

business area logo Core Business Areas

  • OPTAVIA: OPTAVIA is MEDIFAST's primary business segment, offering structured weight-loss programs and products through independent coaches.

leadership logo Leadership and Structure

MEDIFAST's leadership includes its CEO, Dan Chard, and a board of directors. The company operates with a direct-selling model through its OPTAVIA coaches.

Top Products and Market Share

overview logo Key Offerings

  • OPTAVIA Program & Fuelings: OPTAVIA offers a structured weight management program that includes meal replacements, known as Fuelings, and support from independent coaches. Market share information is difficult to pinpoint exactly. Competitors are Weight Watchers, Nutrisystem, and Herbalife. Revenue from this segment accounts for the majority of MEDIFAST's revenue.

Market Dynamics

industry overview logo Industry Overview

The weight management industry is competitive, encompassing various approaches from diet plans to surgery. The market is influenced by health trends and consumer preferences.

Positioning

MEDIFAST is positioned in the weight management industry with a focus on meal replacements and coaching. Its competitive advantage lies in the OPTAVIA program and network of coaches.

Total Addressable Market (TAM)

The global weight management market is estimated to be around $250 billion. Medifast has a small percentage of this overall market. They have potential for growth and market penetration.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition within its niche
  • Network of independent OPTAVIA coaches
  • Recurring revenue model through meal replacements

Weaknesses

  • Reliance on the direct-selling model, which can be susceptible to regulatory changes
  • Customer attrition rate
  • Sensitivity to economic downturns

Opportunities

  • Expansion into new geographic markets
  • Development of new products and services
  • Leveraging digital platforms for coach training and customer engagement

Threats

  • Increased competition from other weight management programs
  • Changes in consumer preferences and dietary trends
  • Regulatory scrutiny of direct-selling practices
  • Recession

Competitors and Market Share

competitor logo Key Competitors

  • WW
  • NUTR
  • HLAL

Competitive Landscape

MEDIFAST competes with various weight management programs, focusing on a direct-selling model. Competitors such as WW offer more community meetings, while Nutrisystem focuses on pre-packaged meals.

Growth Trajectory and Initiatives

Historical Growth: MEDIFAST has experienced growth, particularly with the OPTAVIA program, but growth rates fluctuate. Check their reports for previous periods

Future Projections: Future growth is dependent on the execution of strategic initiatives and market conditions. Review reports from financial analysis websites for estimations

Recent Initiatives: MEDIFAST is expanding into new markets and investing in digital platforms. Details are available in press releases.

Summary

MEDIFAST operates in the competitive weight management industry, primarily through its OPTAVIA program and coach network. The company has strengths in its brand and recurring revenue, but faces risks from competition, regulation, and consumer trends. Medifast's future success hinges on expanding its market presence, managing its direct-selling model effectively, and adapting to changing consumer preferences. Despite a recognizable brand, they will need to find more strategic partnerships to better penetrate the market.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • MEDIFAST INC's SEC Filings (10-K, 10-Q), Press Releases, Investor Relations Website, Market Research Reports

Disclaimers:

The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may vary.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About MEDIFAST INC

Exchange NYSE
Headquaters Baltimore, MD, United States
IPO Launch date 1993-12-31
Executive Chairman & CEO Mr. Daniel R. Chard
Sector Consumer Cyclical
Industry Personal Services
Full time employees 504
Full time employees 504

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.